07/31/2025 8:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:15 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/13/2025 3:19 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/02/2025 4:24 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for BDRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
05/30/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 4:59 PM | Biodexa Pharmaceuticals (Subject) C/M CAPITAL PARTNERS, LP (Filed by)
| Form SCHEDULE 13G | |
05/22/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/15/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 7:31 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
04/29/2025 3:15 PM | Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/17/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2025 7:41 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2025 7:43 AM | Biodexa Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 3:30 PM | Biodexa Pharmaceuticals (Subject) C/M CAPITAL PARTNERS, LP (Filed by)
| Form SCHEDULE 13G | |
02/13/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
01/28/2025 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/22/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 5:27 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:18 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:21 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
HIDDEN IN THE BOOK OF GENESIS… (Ad) “This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth.
Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. Watch Jim Rickards reveal the Old Testament Wealth Code |
01/21/2025 5:24 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/17/2025 3:49 PM | Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
01/17/2025 3:21 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:09 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:18 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/27/2024 4:15 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 10:56 AM | Biodexa Pharmaceuticals (Subject) Brio Capital Master Fund Ltd. (Filed by)
| Form SC 13G/A | |
11/05/2024 5:09 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/01/2024 4:18 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/15/2024 4:14 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/26/2024 7:42 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/19/2024 3:30 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 7:40 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Altucher: Trump’s Great Gain is starting (Ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. See Altucher’s Trump crypto prediction here |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/30/2024 3:38 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
08/20/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/12/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |